多层纳米药物输送系统与空间时空药物释放改善瘤微环境的协同抗癌疗法
Jiahui Cai1, Yibo Yang1, Jia Zhang1
1Nano-biotechnology Key Lab of Hebei Province, Hebei Key Laboratory of Applied Chemistry, College of Environmental and Chemical Engineering, Yanshan University, Qinhuangdao, Hebei Province 066000, People's Republic of China.
Biofabrication
|January 26, 2024
概括
这项研究开发了一种新的纳米药物,它结合了化疗,光热,光动力学和抗炎疗法. 它通过释放药物来响应瘤微环境,有效地向瘤,提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
背景情况:
- 瘤发生涉及炎症,其中循环氧化酶-2 (COX-2) 和前列腺素-2 (PGE-2) 促进瘤生长.
- 瘤缺氧限制了光动力学治疗 (PDT) 的有效性.
- 需要结合疗法来克服瘤的复杂性和治疗耐药性.
研究的目的:
- 开发一种用于多模式癌症治疗的多功能纳米药物.
- 为了实现空间时空控制的药物释放,以改善瘤治疗.
- 为了结合化疗,光热疗法,PDT和抗炎策略.
主要方法:
- 制造一个涂有凝的多多巴胺纳米载体 (PDA@GN).
- 荷载的多克索鲁比 (DOX),绿色氨酸 (ICG),MnO2,和赛莱可西布 (CEL).
- 评估由矩阵金属蛋白酶-2和酸性条件触发的细胞外和细胞内药物释放.
主要成果:
- 细胞外释放的赛莱科克西布 (CEL) 抑制了COX-2/PGE-2通路,减少了炎症和化学抵抗.
- 细胞内释放的DOX,ICG和MnO2增强了瘤细胞的杀死.
- MnO2缓解了瘤缺氧,提高了PDT的疗效,而PDA和ICG提供了协同光热疗法.
结论:
- 这种纳米药物证明了有效的多式疗法对抗瘤.
- 双响应药物释放使得精确的向和协同治疗效果成为可能.
- 这种方法为晚期癌症治疗提供了一个有希望的策略.
相关概念视频
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...